Furthermore, a recent study showed that vaccination of mice with Fox–Fc DNA vaccine/recombinant FOXP3–Fc fusion protein induced a CTL response against FOXP3+ T-regs, which decreased tumor growth and prolonged survival rates [148]. This evidence concerns the gene FOXP3 and neoplasm.